Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Icahn denies attempt to sell Herbalife stock, buys more shares

Published 08/26/2016, 08:03 PM
Updated 08/26/2016, 08:03 PM
© Reuters. Billionaire activist-investor Carl Icahn gives an interview on FOX Business Network's Neil Cavuto show in New York

(Reuters) - Carl Icahn said he did not attempt to sell his Herbalife Ltd (N:HLF) stake, and had instead bought more shares in the health supplements maker, rejecting hedge fund manager Bill Ackman's claim that he had been offered some of Icahn's shares.

Herbalife shares rose 4 percent in extended trading, reversing course after Icahn said he had bought 2.3 million shares on Friday.

"Completely contrary to what Bill Ackman stated on television today, I have never given Jefferies an order to sell any of our Herbalife shares," Icahn said in a statement after market close.

Ackman, who unveiled a $1 billion short bet against Herbalife in 2012, said on CNBC earlier in the day that Icahn's planned stake sale would accelerate the company's downfall.

"I continue to believe in Herbalife," Icahn said, disclosing a 20.78 percent stake in the company.

He held 18.32 percent of Herbalife as of July 15.

Icahn and Ackman have opposing bets on Los Angeles-based Herbalife. Ackman for years has accused Herbalife of running a pyramid scheme and bet that the stock would fall to zero.

The duo even became embroiled in a public war of words, with Icahn famously calling Ackman a "liar" and a "crybaby" in a CNBC interview in 2013.

Icahn on Friday said Ackman had "developed a very bad case of Herbalife obsession."

While Ackman has lost money on his short bet over the years, Icahn has made money but his gains are now at risk of shrinking as the stock has fallen in the last few days.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The investors' comments come a little over a month after the company agreed to pay $200 million and change the way it does business to avoid being labeled a pyramid scheme by U.S. regulators.

Following the settlement with regulators, Herbalife said its board had cleared the way for Icahn to boost his stake in the company to as much as 35 percent.

Investment bank Jefferies Group has been trying to find buyers for Icahn's Herbalife stake for about a month, the Wall Street Journal reported on Friday.

Sources told Reuters on Thursday that Icahn was considering structuring a sale of Herbalife shares.

"We appreciate the support of all of our investors and are particularly grateful to Carl Icahn and the conviction he shares, and continues to show in our business," Herbalife CEO Michael Johnson said.

Ackman could not be reached for comment, while Jefferies was not immediately available for comment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.